To continue using this website, please tell us a
little about yourself:

I am a financial adviser

I am a discretionary fund manager / multimanager

I am a financial paraplanner

I work in financial services

I am a private investor

This site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about cookies on the website and how to delete cookies, see our Privacy and Cookie Policy.

I accept the FE Trustnet cookie policy

For more information Click here




It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table
You are here: Factsheet

OMW Norway AXA Framlington Health

3 FE Trustnet

Underlying Fund

FE Crown Rating ( Underlying )

Fund Objective ( Underlying )

Capital growth through investment in healthcare and medical services and product companies worldwide. Investment will be in producers of pharmaceuticals, biotechnology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies.

Fund Manager ( Underlying )

Mark Hargraves




Primary Asset Class

Fund Size

GBP 1.98m as at 29-May-2015

Downloads ( Underlying )

Unit Name

OMW Norway AXA Framlington Health





Initial Charge


Unit Currency




Annual Charge



NOK 47.86


NOK 47.86

Change (Offer)

-1.26 (-2.63%)

Unit LaunchDate


Performance Overview

Performance Charts

Cumulative Performance

  YTD 3m 6m 1y 3y 5y
Fund 19.97 4.03 18.70 60.59 150.30 204.44
Sector 2.37 -2.07 2.37 6.26 24.08 31.32

Discrete Performance (%)

  2014 2013 2012 2011 2010
Fund 47.52 47.07 8.53 4.85 12.22
Sector 5.16 10.14 6.76 -5.30 8.11

Asset Allocation ( Underlying )

breakdown chart
  Asset Class % of Fund
US Equities 70.01
Swiss Equities 9.84
UK Equities 5.89
Money Market 2.63
German Equities 2.59
Japanese Equities 2.49
Danish Equities 1.91
Canadian Equities 1.31
Israeli Equities 1.21
French Equities 1.02
Australian Equities 0.69
South African Equities 0.41

Regional Breakdown ( Underlying )

breakdown chart
  Region % of Fund
United States 70.01
Switzerland 9.84
United Kingdom 5.89
Cash 2.63
Germany 2.59
Japan 2.49
Denmark 1.91
Canada 1.31
Israel 1.21
France 1.02
Australia 0.69
South Africa 0.41

Sector Breakdown ( Underlying )

breakdown chart
  Sector % of Fund
Specialty Pharma & Pharma 33.74
Healthcare Services & Enabling Technology / Tools 28.03
Biotech Product 21.37
Devices 14.23
Cash 2.63

All prices in Pence Sterling (GBX) unless otherwise specified. Price performance figures are calculated on a bid price to bid price basis with net income (dividends) reinvested. Performance figures are shown in Sterling.

Sign up for email alerts
Stay upto date on the latest fund research from FE
subscribe Readers of this page also looked at:
alter Pru PruFund Growth Fund
alter L&G Distribution
alter Pru PruFund Cautious Fund
alter FL Distribution AL
alter FL Managed